爱尔兰爵士制药的去纤维钠在哪买？

For some patients with leukemia and lymphoma, hematopoietic stem transplantation (HSCT) is the disease and the only hope to regain health. Hepatic veno-occlusive disease (HVOD) is one of the serious complications after hematopoietic stem transplantation (HSCT), and the mortality rate of severe HVOD can be as high as 100%. It is a mixture of single-stranded oligonucleotides with anti-thrombotic and fibrinolytic effects. In recent years, multiple research results have shown that defibrinated sodium is safe and effective in preventing and treating HVOD. Defibrotide is indicated for the treatment of adults and children with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), and renal or pulmonary dysfunction after hematopoietic stem cell transplantation (HSCT).

Jazz Pharmaceuticals Public Limited Company (NASDAQ: JAZZ) was founded in 2003 and is headquartered in Dublin, Ireland. It has 1,620 full-time employees. It is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of pharmaceutical products. On March 30, 2016, the FDA approved the marketing of Jazz Pharmaceuticals' defibrinated sodium for the treatment of adult and pediatric patients with hepatic venous occlusion (VOD) and renal or lung abnormalities after blood or bone marrow hematopoietic stem cell transplantation (HSCT). Hepatic venule occlusion causes edema and reduced blood flow in the liver due to blockage of some blood vessels in the liver. This condition can lead to the most severe liver damage. Defibrotide sodium is the first drug approved by the FDA for the treatment of severe hepatic venule occlusion, a rare and fatal liver disease. For domestic patients, they can obtain Irish Jazz Pharmaceuticals through domestic professional overseas medical service institutions.

Recommended related hot articles: /newsDetail/95921.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.